Last reviewed · How we verify

Acetaminophen 1000mg

Jean Brown Research · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Acetaminophen 1000mg is a Small molecule drug developed by Jean Brown Research. It is currently FDA-approved. Also known as: Tylenol.

Acetaminophen 1000mg is a small molecule medication used to treat various conditions, including pain, as indicated by studies on ClinicalTrials.gov. Its mechanism of action is not specified in the provided information, but it is classified as a small molecule according to ChEMBL.

At a glance

Generic nameAcetaminophen 1000mg
Also known asTylenol
SponsorJean Brown Research
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Acetaminophen 1000mg

What is Acetaminophen 1000mg?

Acetaminophen 1000mg is a Small molecule drug developed by Jean Brown Research.

Who makes Acetaminophen 1000mg?

Acetaminophen 1000mg is developed and marketed by Jean Brown Research (see full Jean Brown Research pipeline at /company/jean-brown-research).

Is Acetaminophen 1000mg also known as anything else?

Acetaminophen 1000mg is also known as Tylenol.

What development phase is Acetaminophen 1000mg in?

Acetaminophen 1000mg is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing